Tacrolimus-based immunosuppression in renal transplantation: 78 experiences in a single Japanese center

Transplant Proc. 2002 Aug;34(5):1666. doi: 10.1016/s0041-1345(02)02972-x.

Authors

M Okamoto¹, Y Omori, Y Kadotani, H Ushigome, K Nakamura, K Akioka, N Yoshimura

Affiliation

¹ Department of Transplantation and Endocrine Surgery, Kyoto Prefectural University of Medicine, 465 Kajicho, Kawaramachi-Hirokoji, 602 Kamigyo-ku, Kyoto, Japan.

PMID: 12176527
DOI: 10.1016/s0041-1345(02)02972-x

No abstract available

Publication types

Clinical Trial
Controlled Clinical Trial
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Child
Dose-Response Relationship, Drug
Graft Rejection / epidemiology
Humans
Immunosuppressive Agents / blood
Immunosuppressive Agents / pharmacokinetics
Immunosuppressive Agents / therapeutic use
Japan
Kidney Transplantation / immunology
Kidney Transplantation / physiology*
Middle Aged
Reoperation
Tacrolimus / blood
Tacrolimus / pharmacokinetics
Tacrolimus / therapeutic use*
Time Factors
Treatment Outcome

Substances

Immunosuppressive Agents
Tacrolimus